 | • レポートコード：MRC2-11QY11541 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はクッシング症候群・先端巨大症治療のグローバル市場について調査・分析したレポートです。種類別（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別クッシング症候群・先端巨大症治療の競争状況、市場シェア ・世界のクッシング症候群・先端巨大症治療市場：種類別市場規模 2015年-2020年（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他） ・世界のクッシング症候群・先端巨大症治療市場：種類別市場規模予測 2021年-2026年（糖質コルチコイド受容体阻害剤、ソマトスタチン、ケトコナゾールHRA、その他） ・世界のクッシング症候群・先端巨大症治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、オンライン薬局） ・世界のクッシング症候群・先端巨大症治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、オンライン薬局） ・北米のクッシング症候群・先端巨大症治療市場分析：米国、カナダ ・ヨーロッパのクッシング症候群・先端巨大症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのクッシング症候群・先端巨大症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のクッシング症候群・先端巨大症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのクッシング症候群・先端巨大症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Novartis、Bristol-Myers Squibb、Corcept Therapeutics、HRA Pharma、Ipsen Biopharmaceuticals ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Cushing’s syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing’s syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly involves symptoms such as enlargement of the hands, feet, forehead, jaw, nose etc. resulting in joint pain, thickening of skin, deepening of the voice, headaches, and vision problems. Other complications include type 2 diabetes, and hypertension. Acromegaly is also caused by production of excess growth hormone (GH). Most cases of Acromegaly is due to the pituitary gland producing excessive growth hormone mostly due a benign tumor, known as a pituitary adenoma.
In terms of value, North America is expected to be the dominant regional market for Cushing’s Syndrome and Acromegaly treatment by 2025 and is expected to expand at a CAGR of 9% over the forecast period.
Market Analysis and Insights: Global Cushing’s Syndrome and Acromegaly Treatment Market
The global Cushing’s Syndrome and Acromegaly Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Cushing’s Syndrome and Acromegaly Treatment Scope and Market Size
Cushing’s Syndrome and Acromegaly Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cushing’s Syndrome and Acromegaly Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Novartis
Bristol-Myers Squibb
Corcept Therapeutics
HRA Pharma
Ipsen Biopharmaceuticals
…
Market segment by Type, the product can be split into
Glucocorticoid Receptor Inhibitors
Somatostatin
Ketoconazole HRA
Others
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Cushing’s Syndrome and Acromegaly Treatment Revenue
1.4 Market by Type
1.4.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Glucocorticoid Receptor Inhibitors
1.4.3 Somatostatin
1.4.4 Ketoconazole HRA
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Perspective (2015-2026)
2.2 Global Cushing’s Syndrome and Acromegaly Treatment Growth Trends by Regions
2.2.1 Cushing’s Syndrome and Acromegaly Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Cushing’s Syndrome and Acromegaly Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Cushing’s Syndrome and Acromegaly Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Cushing’s Syndrome and Acromegaly Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Cushing’s Syndrome and Acromegaly Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Cushing’s Syndrome and Acromegaly Treatment Players by Market Size
3.1.1 Global Top Cushing’s Syndrome and Acromegaly Treatment Players by Revenue (2015-2020)
3.1.2 Global Cushing’s Syndrome and Acromegaly Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Cushing’s Syndrome and Acromegaly Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Cushing’s Syndrome and Acromegaly Treatment Market Concentration Ratio
3.2.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Cushing’s Syndrome and Acromegaly Treatment Revenue in 2019
3.3 Cushing’s Syndrome and Acromegaly Treatment Key Players Head office and Area Served
3.4 Key Players Cushing’s Syndrome and Acromegaly Treatment Product Solution and Service
3.5 Date of Enter into Cushing’s Syndrome and Acromegaly Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Cushing’s Syndrome and Acromegaly Treatment Historic Market Size by Type (2015-2020)
4.2 Global Cushing’s Syndrome and Acromegaly Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
5.2 Global Cushing’s Syndrome and Acromegaly Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Cushing’s Syndrome and Acromegaly Treatment Market Size (2015-2020)
6.2 Cushing’s Syndrome and Acromegaly Treatment Key Players in North America (2019-2020)
6.3 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2015-2020)
6.4 North America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size (2015-2020)
7.2 Cushing’s Syndrome and Acromegaly Treatment Key Players in Europe (2019-2020)
7.3 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2015-2020)
7.4 Europe Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
8 China
8.1 China Cushing’s Syndrome and Acromegaly Treatment Market Size (2015-2020)
8.2 Cushing’s Syndrome and Acromegaly Treatment Key Players in China (2019-2020)
8.3 China Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2015-2020)
8.4 China Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Cushing’s Syndrome and Acromegaly Treatment Market Size (2015-2020)
9.2 Cushing’s Syndrome and Acromegaly Treatment Key Players in Japan (2019-2020)
9.3 Japan Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2015-2020)
9.4 Japan Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Cushing’s Syndrome and Acromegaly Treatment Market Size (2015-2020)
10.2 Cushing’s Syndrome and Acromegaly Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
11 India
11.1 India Cushing’s Syndrome and Acromegaly Treatment Market Size (2015-2020)
11.2 Cushing’s Syndrome and Acromegaly Treatment Key Players in India (2019-2020)
11.3 India Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2015-2020)
11.4 India Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Cushing’s Syndrome and Acromegaly Treatment Market Size (2015-2020)
12.2 Cushing’s Syndrome and Acromegaly Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Cushing’s Syndrome and Acromegaly Treatment Market Size by Type (2015-2020)
12.4 Central & South America Cushing’s Syndrome and Acromegaly Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Cushing’s Syndrome and Acromegaly Treatment Introduction
13.1.4 Pfizer Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Cushing’s Syndrome and Acromegaly Treatment Introduction
13.2.4 Novartis Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Bristol-Myers Squibb
13.3.1 Bristol-Myers Squibb Company Details
13.3.2 Bristol-Myers Squibb Business Overview
13.3.3 Bristol-Myers Squibb Cushing’s Syndrome and Acromegaly Treatment Introduction
13.3.4 Bristol-Myers Squibb Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2015-2020)
13.3.5 Bristol-Myers Squibb Recent Development
13.4 Corcept Therapeutics
13.4.1 Corcept Therapeutics Company Details
13.4.2 Corcept Therapeutics Business Overview
13.4.3 Corcept Therapeutics Cushing’s Syndrome and Acromegaly Treatment Introduction
13.4.4 Corcept Therapeutics Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2015-2020)
13.4.5 Corcept Therapeutics Recent Development
13.5 HRA Pharma
13.5.1 HRA Pharma Company Details
13.5.2 HRA Pharma Business Overview
13.5.3 HRA Pharma Cushing’s Syndrome and Acromegaly Treatment Introduction
13.5.4 HRA Pharma Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2015-2020)
13.5.5 HRA Pharma Recent Development
13.6 Ipsen Biopharmaceuticals
13.6.1 Ipsen Biopharmaceuticals Company Details
13.6.2 Ipsen Biopharmaceuticals Business Overview
13.6.3 Ipsen Biopharmaceuticals Cushing’s Syndrome and Acromegaly Treatment Introduction
13.6.4 Ipsen Biopharmaceuticals Revenue in Cushing’s Syndrome and Acromegaly Treatment Business (2015-2020)
13.6.5 Ipsen Biopharmaceuticals Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Cushing's Syndrome and Acromegaly Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Cushing's Syndrome and Acromegaly Treatment Revenue
Table 3. Ranking of Global Top Cushing's Syndrome and Acromegaly Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Cushing's Syndrome and Acromegaly Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Glucocorticoid Receptor Inhibitors
Table 6. Key Players of Somatostatin
Table 7. Key Players of Ketoconazole HRA
Table 8. Key Players of Others
Table 9. Global Cushing's Syndrome and Acromegaly Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Cushing's Syndrome and Acromegaly Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Cushing's Syndrome and Acromegaly Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions (2015-2020)
Table 13. Global Cushing's Syndrome and Acromegaly Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Cushing's Syndrome and Acromegaly Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Cushing's Syndrome and Acromegaly Treatment Players
Table 20. Global Cushing's Syndrome and Acromegaly Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Players (2015-2020)
Table 22. Global Top Cushing's Syndrome and Acromegaly Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing's Syndrome and Acromegaly Treatment as of 2019)
Table 23. Global Cushing's Syndrome and Acromegaly Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Cushing's Syndrome and Acromegaly Treatment Product Solution and Service
Table 26. Date of Enter into Cushing's Syndrome and Acromegaly Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Cushing's Syndrome and Acromegaly Treatment Market Size Share by Type (2015-2020)
Table 30. Global Cushing's Syndrome and Acromegaly Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Cushing's Syndrome and Acromegaly Treatment Market Size Share by Application (2015-2020)
Table 32. Global Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Cushing's Syndrome and Acromegaly Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Cushing's Syndrome and Acromegaly Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Cushing's Syndrome and Acromegaly Treatment Market Share (2019-2020)
Table 36. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2015-2020)
Table 38. North America Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Cushing's Syndrome and Acromegaly Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Cushing's Syndrome and Acromegaly Treatment Market Share (2019-2020)
Table 42. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2015-2020)
Table 44. Europe Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Cushing's Syndrome and Acromegaly Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Cushing's Syndrome and Acromegaly Treatment Market Share (2019-2020)
Table 48. China Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2015-2020)
Table 50. China Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Cushing's Syndrome and Acromegaly Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Cushing's Syndrome and Acromegaly Treatment Market Share (2019-2020)
Table 54. Japan Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2015-2020)
Table 56. Japan Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Cushing's Syndrome and Acromegaly Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Cushing's Syndrome and Acromegaly Treatment Market Share (2019-2020)
Table 60. Southeast Asia Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Cushing's Syndrome and Acromegaly Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Cushing's Syndrome and Acromegaly Treatment Market Share (2019-2020)
Table 66. India Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2015-2020)
Table 68. India Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Cushing's Syndrome and Acromegaly Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Cushing's Syndrome and Acromegaly Treatment Market Share (2019-2020)
Table 72. Central & South America Cushing's Syndrome and Acromegaly Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Cushing's Syndrome and Acromegaly Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Cushing's Syndrome and Acromegaly Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Cushing's Syndrome and Acromegaly Treatment Market Share by Application (2015-2020)
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Product
Table 79. Pfizer Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2015-2020) (Million US$)
Table 80. Pfizer Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. Bristol-Myers Squibb Company Details
Table 87. Bristol-Myers Squibb Business Overview
Table 88. Bristol-Myers Squibb Product
Table 89. Bristol-Myers Squibb Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2015-2020) (Million US$)
Table 90. Bristol-Myers Squibb Recent Development
Table 91. Corcept Therapeutics Company Details
Table 92. Corcept Therapeutics Business Overview
Table 93. Corcept Therapeutics Product
Table 94. Corcept Therapeutics Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2015-2020) (Million US$)
Table 95. Corcept Therapeutics Recent Development
Table 96. HRA Pharma Company Details
Table 97. HRA Pharma Business Overview
Table 98. HRA Pharma Product
Table 99. HRA Pharma Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2015-2020) (Million US$)
Table 100. HRA Pharma Recent Development
Table 101. Ipsen Biopharmaceuticals Company Details
Table 102. Ipsen Biopharmaceuticals Business Overview
Table 103. Ipsen Biopharmaceuticals Product
Table 104. Ipsen Biopharmaceuticals Revenue in Cushing's Syndrome and Acromegaly Treatment Business (2015-2020) (Million US$)
Table 105. Ipsen Biopharmaceuticals Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Type: 2020 VS 2026
Figure 2. Glucocorticoid Receptor Inhibitors Features
Figure 3. Somatostatin Features
Figure 4. Ketoconazole HRA Features
Figure 5. Others Features
Figure 6. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Cushing's Syndrome and Acromegaly Treatment Report Years Considered
Figure 11. Global Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Cushing's Syndrome and Acromegaly Treatment Market Share by Players in 2019
Figure 16. Global Top Cushing's Syndrome and Acromegaly Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cushing's Syndrome and Acromegaly Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Cushing's Syndrome and Acromegaly Treatment Revenue in 2019
Figure 18. North America Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Cushing's Syndrome and Acromegaly Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
クッシング症候群治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
- バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
- 多嚢胞性卵巣症候群治療の世界市場（～2026年） Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females. Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velv…
- ドラベ症候群治療の世界市場（～2026年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …